Emily Cousins

July 23, 2024 | Connecticut Law Tribune

DoctorNow alleged that the defendants were required to provide full coverage and reimbursement for COVID-19 testing.

By Emily Cousins

3 minute read

July 19, 2024 | Connecticut Law Tribune

"It is long past time that the petitioner be afforded the opportunity to challenge the procedures related to the eyewitness identification used in his criminal case in light of the principles we articulated in 'Dickson,'" the high court held.

By Emily Cousins

4 minute read

July 18, 2024 | Connecticut Law Tribune

In the U.S. District Court for the Middle District of Alabama, CooperSurgical and Femcare denied the allegations, and argued that the claims are preempted by the Medical Device Amendments to the Food, Drug & Cosmetic Act, U.S. Food and Drug Administration regulations and federal laws under the Supremacy Clause of the U.S. Constitution.

By Emily Cousins

3 minute read

July 17, 2024 | Connecticut Law Tribune

"This goes against what's considered to be fair game, and I think lawyers like to play fair," Thomas G. Moukawsher, a former Superior Court judge, said. "They don't like to get tagged as constantly challenging the norms of the profession."

By Emily Cousins

4 minute read

July 16, 2024 | Connecticut Law Tribune

Plaintiff's attorney Erica Nolan said the bill of discovery procedure is a unique Connecticut practice to obtain information. "We think this is a very serious matter, and we will be pursuing it aggressively with the assistant of the Connecticut Superior Court," she said.

By Emily Cousins

3 minute read

July 15, 2024 | Connecticut Law Tribune

"By framing the risk of third-party noncompliance as a mere possibility when they knew the FDA had issued a Form 483 observing such noncompliance at its audit, Defendants did not provide complete information to reasonable investors; thus, the statement was misleading and is actionable," the court said.

By Emily Cousins

3 minute read

July 12, 2024 | Connecticut Law Tribune

"We are disappointed by this ruling and what it means for biopharmaceutical innovation," the company said. "Boehringer Ingelheim shares the goal of ensuring our medicines are affordable and available to people who need them. However, we remain concerned about the detrimental and limiting effects the IRA and its 'negotiation' program will have on the future of innovation for the patients we serve."

By Emily Cousins

3 minute read

July 11, 2024 | Connecticut Law Tribune

Isabel Del Vecchio of Suisman Shapiro, who has settled many dram shop cases, said it is hard for defendants to prevail on summary judgment because determining if someone were "visibly intoxicated" at the time of sale is a question of fact.

By Emily Cousins

4 minute read

July 10, 2024 | Connecticut Law Tribune

"The fallout from this data breach has and will continue to wreak havoc on the healthcare industry," one complaint said.

By Emily Cousins

5 minute read

July 09, 2024 | Connecticut Law Tribune

"There is no purpose occupying a jury's time, the court's time, and the parties' time and resources trying a case than cannot be proven without expert testimony, where the plaintiff has disclosed no expert, or any damages whatsoever, and the time for doing so passed over six months ago," the law firm said.

By Emily Cousins

3 minute read